Search

FDA Bans JUUL Products From US Market Cannabis industry stakeholders weigh in on what the decision could mean for businesses in the cannabis space. By Melissa Schiller On the other hand, Jonathan Havens, co-chair of Saul Ewing’s Cannabis Law Practice and chair of the firm’s Food, Beverage and...

FDA takes another look at CBD, but insiders are skeptical much will change U.S. health regulators are taking their closest look in more than three years at the idea of incorporating cannabinoids into dietary supplements. But hopes are dim that Tuesday’s daylong review by the U.S. Food and Drug...

Saul Ewing LLP served as counsel to Marwin II, LLC, a wholly owned subsidiary of US Wind, Inc., in the application to the Maryland Public Service Commission for, and approval of, approximately 800 megawatts of Maryland Offshore Renewable Energy Credits ("ORECs"). The addition of the extra 800...

In just two months, from mid-November 2020 to mid-January 2021, Saul Ewing LLP's Cannabis Law Practice assisted clients in closing transactions with a combined deal value of more than $520 million. We served as: U.S. counsel to Canaccord Genuity Corp., lead underwriter of an overnight marketed...